These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5628088)

  • 1. Effect of lysostaphin on staphylococcal carriage in infants and children.
    Harris RL; Nunnery AW; Riley HD
    Antimicrob Agents Chemother (Bethesda); 1967; 7():110-2. PubMed ID: 5628088
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.
    Quickel KE; Selden R; Caldwell JR; Nora NF; Schaffner W
    Appl Microbiol; 1971 Sep; 22(3):446-50. PubMed ID: 4330318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.
    Desbois AP; Sattar A; Graham S; Warn PA; Coote PJ
    J Antimicrob Chemother; 2013 Nov; 68(11):2569-75. PubMed ID: 23800902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mupirocin for eradication of nasal carriage of staphylococci.
    Casewell MW; Hill RL
    Lancet; 1989 Jan; 1(8630):154. PubMed ID: 2563063
    [No Abstract]   [Full Text] [Related]  

  • 5. Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.
    Dacre JE; Emmerson AM; Jenner EA
    Lancet; 1983 Oct; 2(8357):1036. PubMed ID: 6138588
    [No Abstract]   [Full Text] [Related]  

  • 6. [The disinfection of inapparent microbial foci in the treatment of furunculosis].
    Worms R
    Cah Med; 1972 Mar; 13(3):219-24. PubMed ID: 5042361
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of mupirocin on nasal carriage of Staphylococcus aureus.
    Bulanda M; Gruszka M; Heczko B
    J Hosp Infect; 1989 Aug; 14(2):117-24. PubMed ID: 2572628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of phosphonomycin in nasal carriers of coagulase-positive staphylococci.
    Smith JW; Sanford JP
    Antimicrob Agents Chemother (Bethesda); 1969; 9():346-8. PubMed ID: 5396512
    [No Abstract]   [Full Text] [Related]  

  • 9. [What is certain in the topical eradication of MRSA from carriers?].
    Dziekan G; Mlangeni D; Daschner FD
    Dtsch Med Wochenschr; 2001 Jun; 126(25-26):761-3. PubMed ID: 11455670
    [No Abstract]   [Full Text] [Related]  

  • 10. Nasal carriage of Staphylococcus pyogenes. I. Lability of carriage in relation to carrier state, environmental staphylococcal load, and antibiotic therapy.
    O'GRADY F; WITTSTADT FB
    Am J Hyg; 1962 Jan; 75():136-45. PubMed ID: 14480873
    [No Abstract]   [Full Text] [Related]  

  • 11. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.
    Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E
    BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of mupirocin in eradicating methicillin-resistant Staphylococcus aureus from nasal discharge in carrying cardiovascular surgical patients].
    Soga Y; Okabayashi H; Shimada I; Enomoto S; Morimoto T; Kamikawa Y; Saito Y; Matsubayashi K; Nagasawa A
    Kyobu Geka; 1999 Aug; 52(9):735-8. PubMed ID: 10453162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reacquisition of staphylococci by treated carriers: a demonstration of bacterial interference.
    Martin RR; White A
    J Lab Clin Med; 1968 May; 71(5):791-7. PubMed ID: 4869637
    [No Abstract]   [Full Text] [Related]  

  • 14. Danish experience of meticillin-resistant Staphylococcus aureus eradication with emphasis on nose-throat colonization and supplementary systemic antibiotic treatment.
    Petersen IS; Christensen JM; Zeuthen AB; Madsen PB
    J Hosp Infect; 2019 Dec; 103(4):461-464. PubMed ID: 31513882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus. The persistent pathogen (second of two parts).
    Sheagren JN
    N Engl J Med; 1984 May; 310(22):1437-42. PubMed ID: 6371536
    [No Abstract]   [Full Text] [Related]  

  • 16. Staphylococcus aureus nasal decolonization strategies: a review.
    Sakr A; Brégeon F; Rolain JM; Blin O
    Expert Rev Anti Infect Ther; 2019 May; 17(5):327-340. PubMed ID: 31012332
    [No Abstract]   [Full Text] [Related]  

  • 17. A STUDY OF NASAL STAPHYLOCOCCAL CARRIAGE IN HOSPITALISED INFANTS.
    HOLLAND PD
    Ir J Med Sci; 1965 Jun; 474():281-8. PubMed ID: 14326627
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment.
    Reagan DR; Doebbeling BN; Pfaller MA; Sheetz CT; Houston AK; Hollis RJ; Wenzel RP
    Ann Intern Med; 1991 Jan; 114(2):101-6. PubMed ID: 1898585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel].
    Dmitrieva NV; Solodovnik FI; Petukhova IN
    Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Staphylocidal activity of Stanicide-fusidinic acid in vitro and its use in the therapy of the nasal staphylococcal carrier state by local administration].
    Bozović M; Nastov D
    Med Pregl; 1983; 36(5-6):205-6. PubMed ID: 6633451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.